© 2021 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2021 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
July 24, 2020
In an interview with CURE®, Dr. Jorge Gomez discussed how recent developments in the assessment of biomarkers within the small cell lung cancer and non-small cell lung cancer space have led to approvals of new and expanded therapies.
July 09, 2020
An expert explains the importance of the fourth approval of the immunotherapy Tecentriq for certain patients with metastatic non-small cell lung cancer who have a high PD-L1 expression.
What Does It Mean to Be a Cancer Survivor?
Becoming an Informed Patient With Rare Cancer
A Step-by-Step Guide to Cancer Genetic Testing
Experiencing Invalidation After a Stage 0 Breast Cancer Diagnosis